Serum brain-derived neurotrophic factor and neurocognitive function in children with type 1 diabetes
Background/purpose: This study aimed to clarify whether brain-derived neurotrophic factor (BDNF) is a biomarker for cognitive dysfunction in children with type 1 diabetes. Methods: We conducted a cross-sectional case–control study of children aged between 6 and 18 years with type 1 diabetes and heal...
Main Authors: | Hui-Ju Chen, Yann-Jinn Lee, Chao-Ching Huang, Yuh-Feng Lin, Sung-Tse Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664620301479 |
Similar Items
-
Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction
by: Xiaowei Tang, et al.
Published: (2019-08-01) -
AAV-Mediated Combination Gene Therapy for Neuropathic Pain: GAD65, GDNF, and IL-10
by: Daewook Kim, et al.
Published: (2020-09-01) -
Brain-derived neurotrophic factor as biomarker
by: Pathum Sookaromdee, et al.
Published: (2020-02-01) -
Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism
by: Seval Erpolat, et al.
Published: (2017-08-01) -
Brain-derived neurotrophic factor in heart failure
by: Mehmet Birhan Yılmaz
Published: (2019-11-01)